A weekly recap of the latest news about Alzheimer’s and dementia
Alzheimer’s Orange County compiles a weekly roundup of the latest news stories and developments about Alzheimer’s and dementia to keep you updated on what’s happening locally and all around the world. Check out this week’s headlines below:
Alzheimer’s risk may be 75% higher for people who eat trans fats
People with higher levels of trans fats in their blood maybe 50% to 75% more likely to develop Alzheimer’s disease or dementia from any cause, according to a new study published Wednesday in the journal Neurology. Read more here.
Biogen Inc. will seek FDA approval for the company’s experimental Alzheimer’s drug, aducanumab. Biogen had pulled the plug on the drug’s clinical trials last spring, but after an analysis of new data, it has decided to revive the nearly abandoned study. Read more here.
Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer’s disease. Read more here.
Doctors in the US have launched a clinical trial with a dozen patients to see whether exposure to flickering lights and low-frequency sounds can slow the progression of Alzheimer’s disease. Previous animal tests have appeared to boost the brain’s immune cells, making them clear the aberrant proteins that build up in Alzheimer’s. Read more here.